TickerFacts.

Dermata Therapeutics, Inc. (DRMA): Cash & Equivalents

Annual figures by period end, from SEC filings.

$7.52M
As of 2025-12-31
$4.41M
As of 2026-06-30
+6.4%
3-year compound annual growth
+70.0%
5-year compound annual growth
$10.80M2020-12-31: $530.4K2021-12-31: $10.80M2022-12-31: $6.24M2024-12-31: $3.16M2025-12-31: $7.52M$7.52M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$7.52M+137.9%2026-03-26, Balance as of period end
2024-12-31$3.16Mn/a2026-03-26, Balance as of period end
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$6.24M-42.2%2023-02-21, Balance as of period end
2021-12-31$10.80Mn/m2023-02-21, Balance as of period end
2020-12-31$530.4Kn/a2022-03-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Dermata Therapeutics, Inc. (DRMA)2025-12-31$7.52M+137.9%
Processa Pharmaceuticals, Inc. (PCSA)2025-12-31$5.54M+364.8%
GT Biopharma, Inc. (GTBP)2025-12-31$6.81M+72.4%
Silo Pharma, Inc. (SILO)2025-12-31$4.75M+21.6%
Rocket One Inc. (RKTO)2025-12-31$6.25M-11.2%
Oncolytics Biotech Inc (ONCY)2025-12-31$5.20M-53.0%
Lunai Bioworks Inc. (LNAI)2025-06-30$92.7K-58.0%
Revium Rx. (RVRC)2025-12-31$1.68M-48.7%
Ensysce Biosciences, Inc. (ENSC)2025-12-31$4.31M+23.1%

Compare DRMA, PCSA, GTBP, SILO side by side · Screen every company in Pharmaceutical Preparations ↗